MONDO_0018473 (hyperlipoproteinemia type 3) can be described as follows. Hyperlipoproteinemia (HLP) type 3 is a rare combined hyperlipidemia characterized by high levels of cholesterol and triglycerides, transported by intermediate density lipoproteins (IDLs), and a high risk of premature atherosclerosis and cardiovascular disease. Also known as: Broad-betalipoproteinemia, HLP type 3, carbohydrate induced hyperlipemia, dyslipidaemia type 3, dyslipidemia type 3, familial dysbetalipoproteinemia, familial hyperlipoproteinemia type 3, familial type 3 hyperlipoproteinemia.